The traditional multi-dose eye drops bottles sometimes let cross contamination happen, they are not so convenient in use and contain preservatives. The company specializing in development & manufacture of unique formulations drugs is offering to market a newly developed eye-drops single-dose unit (further: unit). The unit is obtained in a pre moulded way. It has tamper evident cap, it provides calibrated predetermined drop, it is armed with ophthalmic tip for smooth and safe edges, has guaranteed sterility for 12 hours. The unit is world new, patent pending. The offered unit is assumed for people suffering from dry eye syndrome, e.g. sore eyes, fatigue, itchiness, redness, allergy etc.
The product is intended to pharmaceutical industry / market. The company is a family owned Israeli pharmaceutical manufacturer engaged and specialized in development, production, distribution and marketing of pharmaceuticals (Rx and OTC), special nutritional supplements and medical devices. The company was stablished in 1946. The company uses modern tools and approach in their activity, participates in medical congresses, conventions, exhibitions; advertises in medical journals and websites & possesses its own one. The company is looking for commercial agency & distribution services agreements for it's products in order to penetrate different markets in Europe and Asia.